About Prosper 2B (Prospective Observational Study in Patients with Mitochondrial Depletion Syndrome, RRM2B)
The Prosper 2B study is a research study funded by The Lily Foundation and Mito Foundation and run by The Newcastle upon Tyne Hospitals NHS Foundation Trust along with Newcastle University. It is a single centre study and all participants will be seen in Newcastle upon Tyne.
The aim of the study is to collect detailed information on the symptoms and clinical signs associated with RRM2B-releated mitochondrial disease. The information will be used to build up a profile of symptoms and clinical signs usually associated with this condition.
This detailed information can then be used to determine future research themes and to contribute to the design of clinical trials of potential new treatments.
To be considered for the study, patients must be aged 11 years or over and have a genetically proven diagnosis of recessive RRM2B-related mitochondrial disease.
Study participants will be required to attend the study centre in Newcastle upon Tyne for two study visits which will occur over a 12 month period. The study visits, which will take place over at least 2 days, will include a number of assessments including MRI scans, blood tests and functional capacity. There will also be additional, optional study visits at 4 months and 8 months.
If you are a patient who would like further information about Prosper 2B, please contact Jan Gebbie or Dr Albert Lim, telephone: 0191 208 3105, email: [email protected]